Literature DB >> 24111526

Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents.

P J Wermuth1, S A Jimenez.   

Abstract

The gadolinium-based contrast agent (GdBCA) Omniscan activates human macrophages through Toll-like receptor (TLR)-4 and TLR-7 signalling. To explore the mechanisms responsible we compared the ability of linear and macrocyclic GdBCA to induce a type I interferon signature and a proinflammatory/profibrotic phenotype in normal human monocytes in vitro. Expression of genes associated with type I interferon signalling and inflammation and production of their corresponding proteins were determined. Both linear and macrocyclic GdBCA stimulated expression of multiple type I interferon-regulated genes and the expression of numerous chemokines, cytokines and growth factors in normal human peripheral blood monocytes. There was no correlation between the magnitude of the measured response and the Gd chelate used. To explore the mechanisms responsible for GdBCA induction of fibrosis in nephrogenic systemic fibrosis (NSF) in vitro, normal human dermal fibroblasts were incubated with GdBCA-treated monocyte culture supernatants and the effects on profibrotic gene expression were examined. Supernatants from monocytes exposed to all GdBCA stimulated types I and III collagen, fibronectin and α-smooth muscle actin (α-SMA) expression in normal dermal fibroblasts. The results indicate that the monocyte activation induced by GdBCA may be the initial step in the development of GdBCA associated fibrosis in NSF.
© 2013 British Society for Immunology.

Entities:  

Keywords:  gadolinium-based contrast agent; macrophages; nephrogenic systemic fibrosis; tissue fibrosis; type I interferon

Mesh:

Substances:

Year:  2014        PMID: 24111526      PMCID: PMC3898560          DOI: 10.1111/cei.12211

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Activation of cytokine expression occurs through the TNFα/NF-κB-mediated pathway in birnavirus-infected cells.

Authors:  Wei-Lun Wang; Wangta Liu; Hong-Yi Gong; Jiann-Ruey Hong; Ching-Chun Lin; Jen-Leih Wu
Journal:  Fish Shellfish Immunol       Date:  2011-01-25       Impact factor: 4.581

2.  Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.

Authors:  Jamie C Kendrick-Jones; David M Voss; Janak R De Zoysa
Journal:  Nephrology (Carlton)       Date:  2011-02       Impact factor: 2.506

3.  Collagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agent.

Authors:  Patricia A Perone; Stephanie L Weber; Marissa DaSilva; Tejaswi Paruchuri; Narasimharao Bhagavathula; Muhammad N Aslam; Michael K Dame; Kent J Johnson; Richard D Swartz; James Varani
Journal:  Invest Radiol       Date:  2010-01       Impact factor: 6.016

4.  NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication.

Authors:  Junmei Wang; Suresh H Basagoudanavar; Xingyu Wang; Emily Hopewell; Randy Albrecht; Adolfo García-Sastre; Siddharth Balachandran; Amer A Beg
Journal:  J Immunol       Date:  2010-07-07       Impact factor: 5.422

5.  Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.

Authors:  Brandon W Higgs; Zheng Liu; Barbara White; Wei Zhu; Wendy I White; Chris Morehouse; Philip Brohawn; Peter A Kiener; Laura Richman; David Fiorentino; Steven A Greenberg; Bahija Jallal; Yihong Yao
Journal:  Ann Rheum Dis       Date:  2011-07-28       Impact factor: 19.103

6.  NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis.

Authors:  Francesco Del Galdo; Peter J Wermuth; Sankar Addya; Paolo Fortina; Sergio A Jimenez
Journal:  Ann Rheum Dis       Date:  2010-11       Impact factor: 19.103

7.  Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.

Authors:  Michael Edward; Jean A Quinn; A David Burden; Ben B Newton; Alan G Jardine
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

8.  Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.

Authors:  Ersan Altun; Diego R Martin; Rebecca Wertman; Aida Lugo-Somolinos; Edwin R Fuller; Richard C Semelka
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

9.  Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents.

Authors:  Peter J Wermuth; Francesco Del Galdo; Sergio A Jiménez
Journal:  Arthritis Rheum       Date:  2009-05

Review 10.  Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.

Authors:  Jean-Marc Idée; Marc Port; Anne Dencausse; Eric Lancelot; Claire Corot
Journal:  Radiol Clin North Am       Date:  2009-09       Impact factor: 2.303

View more
  10 in total

Review 1.  Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.

Authors:  Kerry A Layne; Paul I Dargan; John R H Archer; David M Wood
Journal:  Br J Clin Pharmacol       Date:  2018-08-17       Impact factor: 4.335

2.  Type of MRI contrast, tissue gadolinium, and fibrosis.

Authors:  Catherine Do; Jeffrey L Barnes; Chunyan Tan; Brent Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-06

3.  Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation.

Authors:  Christian Schmidt-Lauber; Lukas Bossaller; Hani H Abujudeh; Gregory I Vladimer; Anette Christ; Katherine A Fitzgerald; Eicke Latz; Ellen M Gravallese; Ann Marshak-Rothstein; Jonathan Kay
Journal:  Ann Rheum Dis       Date:  2014-06-09       Impact factor: 19.103

4.  Acute Chelation Therapy-Associated Changes in Urine Gadolinium, Self-reported Flare Severity, and Serum Cytokines in Gadolinium Deposition Disease.

Authors:  Holden T Maecker; Janet C Siebert; Yael Rosenberg-Hasson; Lorrin M Koran; Miguel Ramalho; Richard C Semelka
Journal:  Invest Radiol       Date:  2021-06-01       Impact factor: 10.065

Review 5.  Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Authors:  Moshe Rogosnitzky; Stacy Branch
Journal:  Biometals       Date:  2016-04-06       Impact factor: 2.949

6.  Exposure of Macrophages to Low-Dose Gadolinium-Based Contrast Medium: Impact on Oxidative Stress and Cytokines Production.

Authors:  Te-I Weng; Huang Jen Chen; Chen-Wen Lu; Yu-Chin Ho; Jia-Lun Wu; Shing-Hwa Liu; Jong-Kai Hsiao
Journal:  Contrast Media Mol Imaging       Date:  2018-12-02       Impact factor: 3.161

7.  An initial investigation of serum cytokine levels in patients with gadolinium retention.

Authors:  Holden T Maecker; Weiqi Wang; Yael Rosenberg-Hasson; Richard C Semelka; Joseph Hickey; Lorrin M Koran
Journal:  Radiol Bras       Date:  2020 Sep-Oct

Review 8.  Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates.

Authors:  Robert J McDonald; Deborah Levine; Jeffrey Weinreb; Emanuel Kanal; Matthew S Davenport; James H Ellis; Paula M Jacobs; Robert E Lenkinski; Kenneth R Maravilla; Martin R Prince; Howard A Rowley; Michael F Tweedle; Herbert Y Kressel
Journal:  Radiology       Date:  2018-09-11       Impact factor: 11.105

9.  Dynamic Serial Cytokine Measurements During Intravenous Ca-DTPA Chelation in Gadolinium Deposition Disease and Gadolinium Storage Condition: A Pilot Study.

Authors:  Holden T Maecker; Janet C Siebert; Yael Rosenberg-Hasson; Lorrin M Koran; Miguel Ramalho; Richard C Semelka
Journal:  Invest Radiol       Date:  2022-01-01       Impact factor: 6.016

10.  Effects of Gadolinium-Based Contrast Agents on Thyroid Hormone Receptor Action and Thyroid Hormone-Induced Cerebellar Purkinje Cell Morphogenesis.

Authors:  Winda Ariyani; Toshiharu Iwasaki; Wataru Miyazaki; Erdene Khongorzul; Takahito Nakajima; Satomi Kameo; Hiroshi Koyama; Yoshito Tsushima; Noriyuki Koibuchi
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-26       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.